Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA G-quadruplexes (RG4s) are non-canonical secondary structures formed within guanine-rich RNA sequences through Hoogsteen base pairing, which organizes four guanine bases into a planar G-tetrad [1]. These structures are highly stable and prevalent throughout the human transcriptome, particularly within the untranslated regions (UTRs) and splicing junctions of messenger RNAs [2]. RG4s function as critical post-transcriptional regulators, influencing processes such as translation efficiency, alternative splicing, and mRNA stability [3]. In oncology, RG4s are frequently located in the transcripts of potent proto-oncogenes like MYC, KRAS, and NRAS, where their stabilization by small molecules can downregulate protein expression and inhibit tumor progression [4]. Beyond cancer, RG4s are implicated in the pathogenesis of neurodegenerative diseases, such as ALS and FTD, where they contribute to the formation of toxic RNA aggregates and sequester essential RNA-binding proteins [5]. Therapeutic targeting of RG4s involves the use of small-molecule ligands designed to stabilize these structures, offering a novel approach to modulating gene expression and inhibiting viral replication in pathogens like HIV-1 and SARS-CoV-2 [6]. However, a major challenge in the clinical development of RG4-targeted therapies is achieving sufficient specificity to avoid cross-reactivity with DNA G-quadruplexes and minimizing global effects on the cellular translatome [4]. Sources: [1] Kwok, C. K., et al. (2016). Nature Methods, 13(10), 841-844. [2] Fay, M. M., et al. (2017). Molecules, 22(4), 497. [3] Cammas, A., & Millevoi, S. (2017). Nucleic Acids Research, 45(4), 1566-1579. [4] Xu, S., et al. (2021). Signal Transduction and Targeted Therapy, 6(1), 1-20. [5] Simone, R., et al. (2015). Scientific Reports, 5, 16532. [6] Ruggiero, E., & Richter, S. N. (2018). Nucleic Acids Research, 46(11), 5369-5383.
Small molecule ligands interact with RNA G-quadruplexes primarily through pi-pi stacking with the external G-tetrads and electrostatic interactions with the phosphate backbone or loops [1][3]. Stabilization of the RG4 structure in the 5' UTR of mRNA creates a physical barrier that inhibits the scanning of the 43S pre-initiation complex or the progression of the ribosome, thereby suppressing translation [2]. In other contexts, stabilization can modulate alternative splicing by masking or exposing splice sites, or interfere with the binding of RNA-binding proteins (RBPs) that regulate mRNA decay or transport [4].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA G-quadruplex (RG4).